Natera Company Profile (NASDAQ:NTRA)

About Natera (NASDAQ:NTRA)

Natera logoNatera, Inc. is a diagnostics company. The Company is engaged in the discovery, development and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother; Horizon Carrier Screening to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children; Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle to select embryos with the probability of becoming healthy children; Anora Products of Conception test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing, to determine paternity by analyzing the fragments of fetal deoxyribonucleic acid in a pregnant mother's blood and a blood sample from the alleged father(s).

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Diagnostic & Testing Substances
  • Sub-Industry: N/A
  • Symbol: NASDAQ:NTRA
  • CUSIP: N/A
  • Web:
  • Market Cap: $672.21 million
  • Outstanding Shares: 53,223,000
Average Prices:
  • 50 Day Moving Avg: $13.09
  • 200 Day Moving Avg: $12.61
  • 52 Week Range: $7.88 - $13.49
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -12.38
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $203.71 million
  • Price / Sales: 3.30
  • Book Value: $0.96 per share
  • Price / Book: 13.16
  • EBIDTA: ($118,850,000.00)
  • Net Margins: -62.64%
  • Return on Equity: -137.46%
  • Return on Assets: -64.82%
  • Current Ratio: 1.25%
  • Quick Ratio: 1.18%
  • Average Volume: 278,000 shs.
  • Beta: 2.32
  • Short Ratio: 9.5

Frequently Asked Questions for Natera (NASDAQ:NTRA)

What is Natera's stock symbol?

Natera trades on the NASDAQ under the ticker symbol "NTRA."

How were Natera's earnings last quarter?

Natera, Inc. (NASDAQ:NTRA) posted its quarterly earnings results on Tuesday, August, 8th. The company reported ($0.52) EPS for the quarter, meeting the Zacks' consensus estimate of ($0.52). The company earned $53.60 million during the quarter, compared to analyst estimates of $50.57 million. Natera had a negative net margin of 62.64% and a negative return on equity of 137.46%. The firm's revenue was up 3.1% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.46) EPS. View Natera's Earnings History.

When will Natera make its next earnings announcement?

Natera is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for Natera.

Where is Natera's stock going? Where will Natera's stock price be in 2017?

4 brokerages have issued twelve-month target prices for Natera's shares. Their predictions range from $13.00 to $20.00. On average, they expect Natera's stock price to reach $15.75 in the next twelve months. View Analyst Ratings for Natera.

What are analysts saying about Natera stock?

Here are some recent quotes from research analysts about Natera stock:

  • 1. According to Zacks Investment Research, "Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. " (8/12/2017)
  • 2. Cowen and Company analysts commented, "Subsequent to the company's Q4 conference call (last week), we are reducing our estimates to reflect management commentary and 2017 guidance. While we believe the risk/reward is likely attractive at current levels, we are also reducing our price target to reflect our new revenue forecast and the heavy-H2 weighting of 2017 expectations...NTRA reported Q4 results last week and provided 2017 revenue guidance. In advance of the company's conference call (link to note), we had reduced our revenue estimates for Q4 and for 2017, by $1.5MM and $13MM, respectively, to reflect our estimated impact of the termination of the company's distribution agreement with BioReference Labs. Our reductions put us at the low end of the range of sell side estimates. Unfortunately, our estimates were not low enough for either period. Shares have traded off ~15% since the announcement and are off nearly 30% YTD." (3/14/2017)

Who are some of Natera's key competitors?

Who are Natera's key executives?

Natera's management team includes the folowing people:

  • Matthew Rabinowitz Ph.D., Chairman of the Board, President, Chief Executive Officer, Co-Founder
  • Jonathan Sheena, Co-Founder, Chief Technology Officer, Director
  • Michael Burkes Brophy, Chief Financial Officer
  • Roelof Frederick Botha, Lead Independent Director
  • Todd C. Cozzens, Independent Director
  • Edward C. Driscoll Jr. Ph.D., Independent Director
  • James I. Healy M.D. Ph.D., Independent Director
  • Gail Boxer Marcus, Independent Director

When did Natera IPO?

(NTRA) raised $101 million in an IPO on Thursday, July 2nd 2015. The company issued 6,300,000 shares at $15.00-$17.00 per share. Morgan Stanle, Cowen and Company and Piper Jaffray served as the underwriters for the IPO and Baird and Wedbush Pacgrow were co-managers.

Who owns Natera stock?

Natera's stock is owned by a number of of institutional and retail investors. Top institutional investors include Capital World Investors (7.93%), Jennison Associates LLC (4.46%), Vanguard Group Inc. (4.28%), Sofinnova Management VIII L.L.C. (2.93%), Macquarie Group Ltd. (2.00%) and Franklin Resources Inc. (1.97%). Company insiders that own Natera stock include Herm Rosenman, Jonathan Sheena, Matthew Rabinowitz and Roelof Botha. View Institutional Ownership Trends for Natera.

Who sold Natera stock? Who is selling Natera stock?

Natera's stock was sold by a variety of institutional investors in the last quarter, including Tekla Capital Management LLC, Citadel Advisors LLC, Nationwide Fund Advisors, Prudential Financial Inc., Capital Impact Advisors LLC, Hamilton Lane Advisors LLC and Goldman Sachs Group Inc.. Company insiders that have sold Natera stock in the last year include Herm Rosenman, Jonathan Sheena and Matthew Rabinowitz. View Insider Buying and Selling for Natera.

Who bought Natera stock? Who is buying Natera stock?

Natera's stock was bought by a variety of institutional investors in the last quarter, including Macquarie Group Ltd., Broadview Advisors LLC, Vanguard Group Inc., Kornitzer Capital Management Inc. KS, Asymmetry Capital Management L.P., Spark Investment Management LLC, Northern Trust Corp and PDT Partners LLC. View Insider Buying and Selling for Natera.

How do I buy Natera stock?

Shares of Natera can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Natera's stock price today?

One share of Natera stock can currently be purchased for approximately $12.63.

MarketBeat Community Rating for Natera (NASDAQ NTRA)
Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  110 (Vote Outperform)
Underperform Votes:  85 (Vote Underperform)
Total Votes:  195
MarketBeat's community ratings are surveys of what our community members think about Natera and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Natera (NASDAQ:NTRA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 4 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $15.75 (24.70% upside)

Analysts' Ratings History for Natera (NASDAQ:NTRA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
9/1/2017Cowen and CompanyReiterated RatingBuy$14.00LowView Rating Details
8/7/2017Morgan StanleyLower Price TargetOverweight -> Overweight$18.00 -> $13.00MediumView Rating Details
5/10/2017Canaccord GenuityBoost Price TargetBuy$14.00 -> $16.00MediumView Rating Details
11/10/2016Benchmark Co.Boost Price TargetBuy$16.00 -> $20.00N/AView Rating Details
3/11/2016Piper Jaffray CompaniesReiterated RatingOverweight$24.00 -> $22.00N/AView Rating Details
3/9/2016Robert W. BairdLower Price TargetOutperform$18.00 -> $15.00N/AView Rating Details
9/28/2015WedbushUpgradeNeutral -> Outperform$20.00N/AView Rating Details
(Data available from 9/19/2015 forward)


Earnings History for Natera (NASDAQ:NTRA)
Earnings by Quarter for Natera (NASDAQ:NTRA)
Earnings History by Quarter for Natera (NASDAQ NTRA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2017($0.47)N/AView Earnings Details
8/8/2017Q2 2017($0.52)($0.52)$50.57 million$53.60 millionViewListenView Earnings Details
5/9/2017Q1 2017($0.61)($0.70)$42.82 million$46.90 millionViewListenView Earnings Details
3/7/2017Q4 2016($0.54)($0.72)$49.82 million$49.30 millionViewListenView Earnings Details
11/9/2016Q316($0.55)($0.50)$48.14 million$53.89 millionViewListenView Earnings Details
8/4/2016Q216($0.48)($0.46)$50.64 million$52.00 millionViewListenView Earnings Details
5/10/2016Q116($0.46)($0.17)$48.17 million$61.90 millionViewListenView Earnings Details
3/8/2016Q415($0.64)($0.47)$45.26 million$52.90 millionViewListenView Earnings Details
11/12/2015Q315($0.46)($0.39)$43.08 million$44.90 millionViewListenView Earnings Details
8/12/2015Q2 2015($0.45)($2.98)$42.69 million$45.09 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Natera (NASDAQ:NTRA)
Current Year EPS Consensus Estimate: $-2.03 EPS
Next Year EPS Consensus Estimate: $-1.02 EPS


Dividend History for Natera (NASDAQ:NTRA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for Natera (NASDAQ:NTRA)
Insider Ownership Percentage: 12.57%
Institutional Ownership Percentage: 59.79%
Insider Trades by Quarter for Natera (NASDAQ:NTRA)
Institutional Ownership by Quarter for Natera (NASDAQ:NTRA)
Insider Trades by Quarter for Natera (NASDAQ:NTRA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
9/6/2017Jonathan SheenaInsiderSell120,000$12.54$1,504,800.00View SEC Filing  
4/5/2017Herm RosenmanDirectorSell1,809$8.55$15,466.95View SEC Filing  
1/4/2017Herm RosenmanCFOSell1,849$11.87$21,947.63View SEC Filing  
12/22/2016Jonathan SheenaInsiderSell16,213$12.00$194,556.00View SEC Filing  
12/20/2016Jonathan SheenaInsiderSell1,087$12.00$13,044.00View SEC Filing  
12/13/2016Jonathan SheenaInsiderSell2,700$12.00$32,400.00View SEC Filing  
12/6/2016Herm RosenmanCFOSell1,828$11.83$21,625.24View SEC Filing  
12/5/2016Matthew RabinowitzCEOSell14,021$12.02$168,532.42View SEC Filing  
12/1/2016Matthew RabinowitzCEOSell56,072$12.01$673,424.72View SEC Filing  
11/28/2016Matthew RabinowitzCEOSell146,756$12.50$1,834,450.00View SEC Filing  
11/21/2016Jonathan SheenaInsiderSell32,505$12.00$390,060.00View SEC Filing  
11/3/2016Herm RosenmanCFOSell1,852$7.98$14,778.96View SEC Filing  
10/6/2016Herm RosenmanCFOSell1,773$11.53$20,442.69View SEC Filing  
10/5/2016Jonathan SheenaInsiderSell1,600$12.00$19,200.00View SEC Filing  
9/6/2016Herm RosenmanCFOSell1,822$10.21$18,602.62View SEC Filing  
8/2/2016Herm RosenmanCFOSell1,833$12.98$23,792.34View SEC Filing  
7/6/2016Herm RosenmanCFOSell1,824$12.10$22,070.40View SEC Filing  
7/1/2016Matthew RabinowitzCEOSell104,892$12.14$1,273,388.88View SEC Filing  
6/19/2016Jonathan SheenaCTOSell188,442$11.94$2,249,997.48View SEC Filing  
6/19/2016Matthew RabinowitzCEOSell732,831$11.94$8,750,002.14View SEC Filing  
6/19/2016Roelof BothaDirectorBuy837,521$11.94$10,000,000.74View SEC Filing  
6/2/2016Herm RosenmanCFOSell1,806$12.04$21,744.24View SEC Filing  
2/1/2016Jonathan SheenaCTOSell10,000$8.03$80,300.00View SEC Filing  
1/5/2016Matthew RabinowitzCEOSell54,683$10.37$567,062.71View SEC Filing  
1/4/2016Jonathan SheenaCTOSell25,000$10.06$251,500.00View SEC Filing  
12/31/2015Matthew RabinowitzCEOSell111,513$10.83$1,207,685.79View SEC Filing  
12/29/2015Jonathan SheenaCTOSell50,000$10.44$522,000.00View SEC Filing  
12/29/2015Matthew RabinowitzCEOSell83,804$10.62$889,998.48View SEC Filing  
7/8/2015James HealyDirectorBuy350,000$18.00$6,300,000.00View SEC Filing  
7/2/2015James HealyDirectorBuy400,000$22.81$9,124,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Natera (NASDAQ:NTRA)
Latest Headlines for Natera (NASDAQ:NTRA)
DateHeadline logo$55.93 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter - September 11 at 2:32 PM logoNatera, Inc. (NTRA) Insider Jonathan Sheena Sells 120,000 Shares - September 7 at 10:22 PM logoNatera, Inc. (NTRA) Given Buy Rating at Cowen and Company - September 4 at 9:26 PM logoNatera (NTRA) and NanoString Technologies (NSTG) Critical Review - September 4 at 2:12 AM logoNatera, Inc. (NTRA) Given Average Rating of "Hold" by Analysts - September 2 at 2:58 PM logoNatera, Inc. (NTRA) Upgraded to Hold at BidaskClub - August 28 at 7:28 PM logoContrasting Natera (NTRA) & TrovaGene (TROV) - August 26 at 12:22 AM logoNatera Launches Signatera™ Personalized Circulating Tumor DNA Technology for Cancer Research - August 22 at 12:54 AM logo-$0.46 EPS Expected for Natera, Inc. (NTRA) This Quarter - August 21 at 2:22 PM logoHead-To-Head Review: Biocept (BIOC) and Natera (NTRA) - August 16 at 8:34 PM logoETFs with exposure to Natera, Inc. : August 14, 2017 - August 15 at 4:24 AM logoFinancial Survey: NanoString Technologies (NSTG) versus Natera (NTRA) - August 13 at 1:40 PM logoNatera, Inc. (NASDAQ:NTRA) Lowered to "Sell" at Zacks Investment Research - August 12 at 7:02 PM logoHead-To-Head Contrast: Lantheus Holdings (LNTH) vs. Natera (NASDAQ:NTRA) - August 11 at 9:04 PM logoNatera, Inc. breached its 50 day moving average in a Bullish Manner : NTRA-US : August 10, 2017 - August 11 at 7:06 AM logoNatera, Inc. (NASDAQ:NTRA) Issues Quarterly Earnings Results, Meets Estimates - August 9 at 9:20 PM logoNatera Reports Second Quarter 2017 Financial Results - August 9 at 5:33 AM logoEdited Transcript of NTRA earnings conference call or presentation 8-Aug-17 8:30pm GMT - August 9 at 5:33 AM logoNatera reports 2Q loss - August 9 at 5:33 AM logoNatera, Inc. (NASDAQ:NTRA) Receives Average Recommendation of "Hold" from Brokerages - August 8 at 2:44 PM logoMorgan Stanley Lowers Natera, Inc. (NTRA) Price Target to $13.00 - August 7 at 10:58 AM logoHead-To-Head Comparison: Biocept (BIOC) vs. Natera (NTRA) - August 6 at 2:22 PM logo$51.13 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter - August 5 at 9:32 AM logoReviewing Natera (NASDAQ:NTRA) and Lantheus Holdings (LNTH) - August 4 at 2:26 PM logoETFs with exposure to Natera, Inc. : August 4, 2017 - August 4 at 6:28 AM logoNatera, Inc. – Value Analysis (NASDAQ:NTRA) : August 4, 2017 - August 4 at 6:28 AM logo-$0.52 Earnings Per Share Expected for Natera, Inc. (NTRA) This Quarter - August 3 at 10:18 AM logoNatera Inc. Announces Second Quarter 2017 Earnings Conference Call - August 2 at 6:26 AM logoFinancial Comparison: Natera (NTRA) versus Lantheus Holdings (LNTH) - August 1 at 7:50 AM logoLarge Study Shows Natera’s Panorama Prenatal Screen To Be Highly Accurate in Identifying DNA Microdeletions Associated with Serious Health Implications - July 31 at 11:15 PM logoNatera, Inc. breached its 50 day moving average in a Bearish Manner : NTRA-US : July 21, 2017 - July 22 at 7:08 AM logoHead-To-Head Survey: Lantheus Holdings (LNTH) vs. Natera (NASDAQ:NTRA) - July 18 at 10:15 AM logo$50.23 Million in Sales Expected for Natera, Inc. (NTRA) This Quarter - July 14 at 4:21 PM logoNatera, Inc. (NASDAQ:NTRA) Given Average Recommendation of "Hold" by Analysts - July 14 at 3:19 PM logoNatera Inc (NASDAQ:NTRA) Rating Lowered to Sell at Zacks Investment Research - July 13 at 12:50 AM logo Brokerages Anticipate Natera, Inc. (NTRA) Will Announce Earnings of -$0.52 Per Share - July 12 at 8:18 AM logoETFs with exposure to Natera, Inc. : July 7, 2017 - July 8 at 1:10 PM logoQuotient Limited (QTNT) & Natera (NASDAQ:NTRA) Critical Contrast - July 8 at 7:51 AM logoETFs with exposure to Natera, Inc. : June 26, 2017 - June 27 at 6:45 AM logoNatera, Inc. (NTRA) Receives Average Rating of "Buy" from Brokerages - June 19 at 2:48 PM logoNatera Inc (NTRA) Expected to Post Quarterly Sales of $50.23 Million - June 18 at 10:46 AM logoETFs with exposure to Natera, Inc. : June 16, 2017 - June 16 at 7:54 PM logoZacks: Analysts Expect Natera, Inc. (NTRA) Will Announce Earnings of -$0.52 Per Share - June 16 at 11:14 AM logoNatera, Inc. :NTRA-US: Earnings Analysis: Q1, 2017 By the Numbers : June 14, 2017 - June 14 at 10:56 PM logoNatera Inc (NTRA) Short Interest Down 6.7% in May - June 4 at 11:34 AM logoNatera Inc (NTRA) Receives Average Recommendation of "Buy" from Brokerages - May 23 at 12:31 PM logoNatera Inc (NTRA) Lifted to Buy at Zacks Investment Research - May 14 at 9:32 PM logoNatera Inc (NTRA) Lowered to "Hold" at Zacks Investment Research - May 11 at 8:04 AM logoNatera Inc (NTRA) Announces Quarterly Earnings Results, Misses Estimates By $0.09 EPS - May 10 at 8:28 PM logoNatera's (NTRA) Buy Rating Reaffirmed at Canaccord Genuity - May 10 at 8:20 PM



Natera (NTRA) Chart for Tuesday, September, 19, 2017

This page was last updated on 9/19/2017 by Staff